Zhi Hong Phones & Addresses
-
West Covina, CA
-
San Gabriel, CA
-
Alhambra, CA
-
El Monte, CA
-
Monterey Park, CA
Business Records
Name / Title
Company / Classification
Phones & Addresses
President
F.H.D.L. INVESTMENT GROUP INC
Investor
Investor
3610 S Dover Ct, Rowland Heights, CA 91748
743 E Vly Blvd, San Gabriel, CA 91776
743 E Vly Blvd, San Gabriel, CA 91776
Publications
Us Patents
Pyrrolo[2,3-D]Pyrimidine Nucleoside Analogs
View pageUS Patent:
6831069, Dec 14, 2004
Filed:
Feb 28, 2001
Appl. No.:
09/797549
Inventors:
Robert Tam - Irvine CA
Guangyi Wang - Irvine CA
Johnson Lau - Newport Beach CA
Zhi Hong - Mission Viejo CA
Guangyi Wang - Irvine CA
Johnson Lau - Newport Beach CA
Zhi Hong - Mission Viejo CA
Assignee:
Ribapharm Inc. - Costa Mesa CA
International Classification:
A61K 3134
US Classification:
514 43, 514 49, 536 272, 544280
Abstract:
Compositions and methods for pyrrolo[2,3-d]pyrimidine nucleoside analogs having substituents at the C4â and C5â positions of the ribofuranose moiety are presented. Contemplated compositions exhibit, among other things, anti-cancer and immunomodulating effects at reduced cytotoxicity.
Inhibitors For De Novo-Rna Polymerases And Methods Of Identifying Targets For Same
View pageUS Patent:
6906190, Jun 14, 2005
Filed:
Dec 27, 2002
Appl. No.:
10/330369
Inventors:
Nanhua Yao - Irvine CA, US
Haoyun An - Carlsbad CA, US
Todd Appleby - Laguna Niguel CA, US
Shahul Nilar - Irvine CA, US
Yili Ding - Fountain Valley CA, US
Zhi Hong - Aliso Viejo CA, US
Haoyun An - Carlsbad CA, US
Todd Appleby - Laguna Niguel CA, US
Shahul Nilar - Irvine CA, US
Yili Ding - Fountain Valley CA, US
Zhi Hong - Aliso Viejo CA, US
Assignee:
Ribapharm Inc. - Costa Mesa CA
International Classification:
C07D473/16
C07D473/18
C07D473/30
C07D473/34
A61P031/14
C07D473/18
C07D473/30
C07D473/34
A61P031/14
US Classification:
544276, 544265, 544277, 536 276, 536 2761
Abstract:
A polymerase inhibitor has first moiety coupled to a second moiety via an optional linker in which the first moiety binds to an initiation nucleotide binding site of a polymerase and forms at least two hydrogen bonds with an RNA template strand that is associated with the polymerase, and in which the second moiety comprised a compound that binds to a site proximal to the nucleotide binding site of the polymerase and thereby increases the affinity of the polymerase inhibitor to the polymerase.
Heterocyclic Compounds And Uses Thereof
View pageUS Patent:
6989451, Jan 24, 2006
Filed:
Jun 4, 2003
Appl. No.:
10/455149
Inventors:
Weijian Zhang - Irvine CA, US
William Ricketts - Irvine CA, US
Haoyun An - Carlsbad CA, US
Zhi Hong - Aliso Viejo CA, US
William Ricketts - Irvine CA, US
Haoyun An - Carlsbad CA, US
Zhi Hong - Aliso Viejo CA, US
Assignee:
Valeant Research & Development - Costa Mesa CA
International Classification:
C07D 275/03
A61K 31/425
A61K 31/425
US Classification:
548206, 548213, 548214, 514372
Abstract:
Substituted isothiazole compounds and compositions are provided, wherein particularly preferred compositions and methods are directed towards inhibition of various protein kinases (especially MEK and/or ERK). Consequently, particularly preferred methods include treatment of diseases associated with abnormality in MEK and/or ERK function.
Nucleoside Analogs With Carboxamidine Modified Monocyclic Base
View pageUS Patent:
7638496, Dec 29, 2009
Filed:
Aug 22, 2002
Appl. No.:
10/227235
Inventors:
Robert Tam - Irvine CA, US
Kandasamy Ramasamy - Aliso Viejo CA, US
Zhi Hong - Aliso Viejo CA, US
Johnson Lau - Newport Beach CA, US
Kandasamy Ramasamy - Aliso Viejo CA, US
Zhi Hong - Aliso Viejo CA, US
Johnson Lau - Newport Beach CA, US
Assignee:
Valeant Pharmaceuticals North America - Aliso Viejo CA
International Classification:
A01N 43/04
A61K 31/70
A61K 31/70
US Classification:
514 43, 514 44, 514 45, 536 269, 536 272
Abstract:
Novel nucleoside analog compounds are disclosed. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 and Type 2 activity.
N-Aryl-N'alkyl Sulfamides As Mek Inhibitors
View pageUS Patent:
7842836, Nov 30, 2010
Filed:
Apr 11, 2007
Appl. No.:
11/734234
Inventors:
Shunqi Yan - Irvine CA, US
Jean-Michel Vernier - Laguna Niguel CA, US
Zhi Hong - Irvine CA, US
Jean-Michel Vernier - Laguna Niguel CA, US
Zhi Hong - Irvine CA, US
Assignee:
Ardea Biosciences - Costa Mesa CA
International Classification:
C07C 331/00
A61K 31/10
A61K 31/10
US Classification:
564 79, 514709
Abstract:
This invention concerns N-(ortho phenylaminoaryl), N′-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
Pyridone Sulfonamides And Pyridone Sulfamides As Mek Inhibitors
View pageUS Patent:
7897624, Mar 1, 2011
Filed:
Apr 18, 2007
Appl. No.:
11/737109
Inventors:
Shunqi Yan - Irvine CA, US
Jean-Michel Vernier - Laguna Niguel CA, US
Zhi Hong - Irvine CA, US
Suetying Chow - Irvine CA, US
Jean-Michel Vernier - Laguna Niguel CA, US
Zhi Hong - Irvine CA, US
Suetying Chow - Irvine CA, US
Assignee:
Ardea Biosciences - San Diego CA
International Classification:
A61K 31/4412
C07D 213/64
C07D 213/75
C07D 213/64
C07D 213/75
US Classification:
514349, 514344, 514348, 51425218, 546288, 546296, 546297, 544360
Abstract:
This invention concerns N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N′-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
Sugar Modified Nucleosides As Viral Replication Inhibitors
View pageUS Patent:
20070032448, Feb 8, 2007
Filed:
Oct 2, 2002
Appl. No.:
10/535742
Inventors:
Zhi Hong - Irvine CA, US
Yili Ding - Fountain Valley CA, US
Jean-Luc Girardet - Aliso Viejo CA, US
Weidong Zhong - Laguna Niguel CA, US
Yili Ding - Fountain Valley CA, US
Jean-Luc Girardet - Aliso Viejo CA, US
Weidong Zhong - Laguna Niguel CA, US
International Classification:
A61K 31/7076
US Classification:
514045000, 514049000, 536026100, 536027300, 536027400, 536028300
Abstract:
Various 2′-modified nucleoside analogs and corresponding prodrugs are provided, and particularly contemplated methods of use include use as antiviral agents, and especially as antiviral agents against HCV.
Nucleoside Analogs With Carboxamidine Modified Monocyclic Base
View pageUS Patent:
20090176721, Jul 9, 2009
Filed:
Mar 9, 2009
Appl. No.:
12/400733
Inventors:
Robert Tam - Irvine CA, US
Kanda Ramasamy - Aliso Viejo CA, US
Zhi Hong - Irvine CA, US
Johnson Lau - Newport Beach CA, US
Kanda Ramasamy - Aliso Viejo CA, US
Zhi Hong - Irvine CA, US
Johnson Lau - Newport Beach CA, US
Assignee:
Valeant Pharmaceuticals North America - Aliso Viejo CA
International Classification:
A61K 31/7056
A61P 31/12
A61P 31/18
A61P 31/12
A61P 31/18
US Classification:
514 43
Abstract:
Novel nucleoside analog compounds are disclosed. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Type 1 and Type 2 activity.
Wikipedia
Hei Zhi Hg
View pageHei Zhi Hong (born 18 September 1975) is a Hong Kong wushu athlete. He won a silver medal during the 2006 Asian Games in the taijiquan competition.